Please login to the form below

Not currently logged in
Email:
Password:

Shield

This page shows the latest Shield news and features for those working in and with pharma, biotech and healthcare.

NantKwest rockets on promising pancreatic cancer data

NantKwest rockets on promising pancreatic cancer data

th. patient. The marked difference was this latest patient received an advanced form of the therapy that was engineered to target the PD-L1 antibody that shields cancer from the immune

Latest news

More from news
Approximately 1 fully matching, plus 20 partially matching documents found.

Latest Intelligence

  • Shaping healthcare Shaping healthcare

    that  shield the office from the nearby  M4 motorway have yet to regain their leaves.

  • Significant figures Significant figures

    The liposome technology creates a shield that keeps most of the drug out of direct contact with a patient’s blood, successfully dodging Amikacin’s severe side effects, which include deafness,

  • Hacking Innovation Hacking Innovation

    GrowAir is a transparent shield, consisting of tubes that purify air, which is then aimed into the nose and mouth of the child, and it is intended to replace the masks

  • Cybersecurity Cybersecurity

    A new political agreement to create a new legal structure called the EU-US Privacy Shield is being negotiated. ... Privacy Shield and safe harbour . The Directive requires that personal data can only be transferred outside the EEA to a territory

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

  • New faces at Prime Global, Swordfish Advertising and Wilmington Healthcare New faces at Prime Global, Swordfish Advertising and Wilmington Healthcare

    Also joining Wilmington is Sarah Shield (pictured left), who has worked in the pharmaceutical industry for 14 years. ... Prior to joining the team at Wilmington, Shield was national policy and partnership lead for AstraZeneca’s UK cardiovascular and

  • Shield Therapeutics’ CFO steps down Shield Therapeutics’ CFO steps down

    Richard Jones to leave the group in early 2017. Richard Jones is to step down from his position as chief financial officer at Shield Therapeutics early next year. ... Carl Sterritt, chief executive officer of Shield Therapeutics, said: “Richard has

  • Mereo BioPharma appoints CFO Mereo BioPharma appoints CFO

    2017. Jones joins the rare and specialty diseases clinical-stage company from Shield Therapeutics, where he most recently served as chief financial officer and company secretary. ... His extensive financial experience in healthcare industry, initially as

  • JPA adds to Washington team JPA adds to Washington team

    He previously worked for the agency Trahan, Burden, Charles where he managed marketing objectives for the likes of Blue Cross Blue Shield of Maryland and the Baltimore Ravens.

  • Horizon appoints board chair Horizon appoints board chair

    Shield. He held this role until from 2008 to 2011, when the company was acquired by Alere.

More from appointments
Approximately 2 fully matching, plus 7 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

Planning your clinical trial? Why you need to engage patients sooner
It’s highly likely that clinical studies are deterring patients based on decisions made in the early stages, such as during planning and design....
Patient-centricity in improving patient recruitment advertising
This blog looks into the importance of concepts and patient centricity in patient recruitment....
AI and life sciences
AI: the smart money is on the smart thinking
Looking at the three key areas where AI is being applied: drug discovery, clinical decision-making and clinical trials...

Infographics